-
InnoCare Announces the Acceptance of the Marketing Application of Tafasitamab in Combination with Lenalidomide in the Treatment of Relapsed/Refractory DLBCL in Hong Kong
Time of Update: 2022-09-07
About Nuocheng JianhuaNuocheng Jianhua (Hong Kong Stock Exchange Code: 09969) is a high-tech biopharmaceutical company in the commercialization stage, focusing on the development of a class of new drugs for the treatment of malignant tumors and autoimmune diseases, suitable for the treatment of lymphoma and solid tumors.
-
China's domestic new crown treatment drugs make new progress
Time of Update: 2022-09-07
(Finish)Traditional Chinese Medicine According to Chinese official media news: The reporter recently learned from the scientific research team of the Joint Prevention and Control Mechanism of the State Council that China is actively promoting the research and development of new crown treatment drugs.
-
The Omicron new crown bivalent vaccine booster needle is authorized for emergency use by the US FDA
Time of Update: 2022-09-07
People 12 years of age and older who are eligible for one Pfizer-biontech updated COVID-19 vaccine booster at least two months after completing primary vaccination or receiving the latest booster for any authorized or approved monovalent COVID-19 vaccine.
-
2022 Plant-Based Food Innovation Competition, press the accelerator button to prepare for the event
Time of Update: 2022-09-07
November 8 2022 Plant-Based Food Innovation Competition The winner of the Chinese division will have a chance to win Asian Division (Singapore) Final Qualification Expert-level review and guidance to develop new ideas for development $200,000 Investment (Grand Final Winner) 100+ media exposure opportunities Shared with the same period of exhibition, 100,000 + audience exhibition opportunities Some candidate companies show Nanjing Four Seasons Partner Biotechnology Co.
-
Qingke Bio's "Gene Factory" helps the research and development of small nucleic acid drugs
Time of Update: 2022-09-07
62em; font-family:"Arial"; color:black; margin:0in; } BEIJING, Aug. 31, 2022 /PRNewswire/ -- Recently, the "gene factory" that Qingke Bio has focused on building has made another breakthrough, and for the current rapid development of small nucleic acid drugs, gene factories have broken through the barriers in process scale-up and quality control in the production of upstream raw materials for nucleic acid production, providing high-standard and high-quality core raw materials for small nucleic acid drug companies.
-
Medical executive Li Xilie has created a new start-up investment and financing model
Time of Update: 2022-09-07
62em; font-family:"Arial"; color:black; margin:0in; } VentureBlick's investment and financing platform connects healthcare startups with individual investors with medical backgroundsSINGAPORE, Sept.
62em; font-family:"Arial"; color:black; margin:0in; } VentureBlick's investment and financing platform connects healthcare startups with individual investors with medical backgroundsSINGAPORE, Sept.
-
Review of the Opening Ceremony of the 2022 Spring Class of the Beijing University of Posts and Telecommunications - Emlyon Business School EMBA Program
Time of Update: 2022-09-07
Principal Sun hopes that the students can work hard, live up to their youth, study knowledge, experience the world, and experience life with heart!Professor Isabelle HUAULT, Chairman of the Board of Directors and President of Emlyon Business School, specially sent a video speech from France, and expressed sincere welcome and warm congratulations to the 2022 freshmen .
-
BGI's geodetic gene test kit was CE-IVDD certified
Time of Update: 2022-09-07
Xiao Jingjing, senior product manager at BGI, said: "Screening for thalassemia through genetic testing is crucial so that carriers and high-risk couples can understand their risks and options for reducing them.
-
The New Indication Marketing Application of Nuocheng Jianhua Orelabrutinib in the Treatment of Relapsed/Refractory Marginal Zone Lymphoma was Accepted in China
Time of Update: 2022-08-20
prnbcc{ BORDER-COLLAPSE: COLLAPSE; BORDER-TOP:1pt black; BORDER-RIGHT:1pt black; BORDER-BOTTOM:1pt black; BORDER-LEFT:1pt black } BEIJING, Aug. 12, 2022 /PRNewswire/ -- InnoCare (HK: 09969), a high-tech biopharmaceutical company, announced today that the Center for Drug Evaluation (CDE) of the China National Medical Products Administration (NMPA) ) has accepted a New Indication Application (sNDA) for the Bruton's tyrosine kinase (BTK) inhibitor orelabrutinib for the treatment of patients with relapsed/refractory marginal zone lymphoma (MZL) .
-
Enter the field of single-cell multi-omics!
Time of Update: 2022-08-20
Proteintech Genomics is developing fully optimized and highly multiplexed proteomic analysis methods to enhance multi-omics capabilities across multiple spatial and single-cell analysis platforms .
Proteintech Genomics is developing fully optimized and highly multiplexed proteomic analysis methods to enhance multi-omics capabilities across multiple spatial and single-cell analysis platforms .
-
BSI Issued ISO 14001 and ISO 45001 International Standard Certificates to WuXi Biologics in Suzhou
Time of Update: 2022-08-20
Suzhou WuXi Biologics was awarded ISO 14001 and ISO 45001 international standard certification by BSI Cai Hui, head of Suzhou WuXi Biologics Base , said, first of all, congratulations to the factory for successfully passing the audit and obtaining the certificate.
-
Xinmai Medical has invested heavily in the research and development of innovative products for the treatment of major diseases in the respiratory field
Time of Update: 2022-08-20
(Suzhou) ("Xinmai Medical"), which focuses on subversive and innovative interventional devices for the treatment of major diseases in the cardiovascular and respiratory fields, With two "innovative medical device" products, and is expected to be approved for the market in 2023 for its renal nerve mapping/selective ablation system for the treatment of hypertension, it will fully promote transbronchoscopy for the treatment of early-stage lung tumors The development process of Precisely Controlled, Hypertonic Solution Assisted RF System .
-
Sartorius Acquires Albumedix, Innovative Products Enable Advanced Therapies
Time of Update: 2022-08-20
/* Style Definitions */ span. prnews_span { font-size:8pt; font-family:"Arial"; color:black; } a. prnews_a { color:blue; } li. prnews_li { font-size:8pt; font-family:"Arial"; color:black; } p. prnews
-
Philips China and Entrepreneur Huikang reached a strategic cooperation to jointly develop a new generation of EMR software CTasy
Time of Update: 2022-08-20
The two parties will cooperate closely and in-depth, relying on the superior resources of both parties, based on the Philips EMR system Tasy , to jointly create an advanced new generation of EMR software - CTasy , which meets the actual needs of China's health care system and can meet future development trends .
-
[Jingderui live broadcast] Pharmaceutical water system operation training
Time of Update: 2022-08-19
[Pharmaceutical Network Technical Articles] At 14:00 pm on August 18th, Jingderui will bring you a live broadcast of the theme of "Pharmaceutical Water System Operation Training".
[Pharmaceutical Network Technical Articles] At 14:00 pm on August 18th, Jingderui will bring you a live broadcast of the theme of "Pharmaceutical Water System Operation Training".
-
Merck becomes one of the first CDMOs to offer complete viral vectors
Time of Update: 2022-08-19
/* Style Definitions */ span. prnews_span { font-size:8pt; font-family:"Arial"; color:black; } a. prnews_a { color:blue; } li. prnews_li { font-size:8pt; font-family:"Arial"; color:black; } p. prnews
-
Luye Pharma's innovative formulation of goserelin microspheres for new breast cancer indications has been accepted for marketing application
Time of Update: 2022-08-19
62em; font-family:"Arial"; color:black; margin:0in; } SHANGHAI, Aug. 15, 2022 /PRNewswire/ -- Luye Pharma Group announced that its new drug candidate, Goserelin Acetate Sustained-Release Microspheres for Injection (LY01005) for the treatment of breast cancer, has been approved for marketing in China.
-
The lecture starts at 14:30 on July 27!
Time of Update: 2022-08-15
[Pharmaceutical Network Technical Article] Nanocellulose uses plant fiber as raw material, rich in resources, green and low-carbon; it has the characteristics of light weight, high strength, and biod
-
Six predictors of bipolar disorder
Time of Update: 2022-08-15
This could reduce precious time in finding the right dose for each patient and could have a life-saving effect," said Karolinska Institutet for Molecular Medicine and said Martin Schalling, professor of surgery and senior author of the study .
-
Immunotherapy may play a role in the treatment of non-metastatic gastroesophageal cancer
Time of Update: 2022-08-15
. Dr. Yin and colleagues conducted a clinical trial to assess whether adding an immunotherapy called pembrolizumab to standard chemoradiotherapy and surgery in patients with gastroesophageal junction adenocarcinoma might increase the number of patients undergoing complete eradication of the tumor in the original location and nearby lymph nodes .
